Quantcast

Latest Merck Stories

2014-08-06 08:32:38

BOSTON, Aug. 6, 2014 /PRNewswire/ -- Columbia Laboratories, Inc.

2014-07-30 08:33:01

Primary efficacy endpoints met in all nine new trials of investigational PCSK9 inhibitor TARRYTOWN, N.Y. and PARIS, July 30, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.

2014-07-30 08:32:55

- Primary efficacy endpoints met in all nine new trials of investigational PCSK9 inhibitor - PARIS and TARRYTOWN, N.Y., July 30, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and

2014-07-30 08:25:08

- Reduces risk of sample contamination associated with filtration and membrane transfer BILLERICA, Mass., July 30, 2014 /PRNewswire/ --

2014-07-30 08:25:06

- Reduces risk of sample contamination associated with filtration and membrane transfer BILLERICA, Mass., July 30, 2014 /PRNewswire/ --

2014-07-29 04:22:01

ROCKLAND, Massachusetts, July 29, 2014 /PRNewswire/ -- - First patient begins treatment in an international Phase II study investigating the efficacy

2014-07-17 08:29:34

"Speaking Up" is Vital, Given the Significant Impact of the Disease on Women WHITEHOUSE STATION, N.J., July 17, 2014 /PRNewswire/ -- Merck (NYSE: MRK), known as MSD outside the United

2014-07-10 12:30:06

TUCSON, Ariz., July 10, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the

2014-07-08 12:28:30

GAITHERSBURG, Md., July 8, 2014 /PRNewswire/ -- Sirnaomics, Inc.


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related